Hospital Ernesto Dornelles
Porto Alegre, Brazil
Private hospital in Porto Alegre, State of Rio Grande do Sul
Av. Ipiranga, 1801 - Azenha, Porto Alegre - RS, 90160-092
About Hospital Ernesto Dornelles
"O Hospital Ernesto Dornelles é uma instituição de saúde privada, possui 312 leitos e 33 especialidades médicas. Inaugurado no dia 30 de junho de 1962, o HED tem uma tradição de pioneirismo e inovações técnicas, na trajetória da medicina gaúcha e brasileira. Nossa missão é proporcionar assistência integral e qualificada à saúde, buscando ser referência médico hospitalar, através de uma empresa autossustentável."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
7
Hoffmann-La Roche
4
Hospital Moinhos de Vento
2
BioAge Labs, Inc.
1
Boehringer Ingelheim
1
Celgene
1
Cristália Produtos Químicos Farmacêuticos Ltda.
1
EMS
1
Eli Lilly and Company
1
Hospital Alemão Oswaldo Cruz
1
Hospital Sirio-Libanes
1
Clinical Trials at Hospital Ernesto Dornelles
During the past decade, Hospital Ernesto Dornelles conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 5 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase III, Evaluate Noninferiority Between Levobupivacaine and Bupivacaine in Spinal Anesthesia.
2016-11-01
2017-01-01
Withdrawn
0
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
2014-11-14
2020-05-25
Completed
358
A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease
2015-03-20
2021-09-07
Completed
1,035
Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
2015-06-08
2026-05-21
Active, not recruiting
900
Efficacy of Bromopride and Simethicone Versus Bromopride in Functional Dyspepsia
2017-01-17
2019-03-11
Completed
339
A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis
2017-07-26
2021-12-24
Completed
138
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
2018-04-13
2030-06-30
Active, not recruiting
1,409
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Ernesto Dornelles" #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Hoffmann-La Roche" with 4 trials
sponsored, "Hospital Moinhos de Vento" with 2 trials sponsored, "BioAge Labs, Inc." with 1 trials sponsored and "Boehringer Ingelheim"
with 1 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Ernesto Dornelles"
#1 collaborator was "BP - A Beneficência Portuguesa de São Paulo" with 1 trials as a collaborator, "Brazilian Research in Intensive Care Network (BRICNet)" with 1 trials as a collaborator, "Hospital Alemão Oswaldo Cruz" with 1 trials as a collaborator, "Hospital Ernesto Dornelles" with 1 trials as a collaborator and "Hospital Israelita Albert Einstein" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Hospital Ernesto Dornelles
According to Clinical.Site data, the most researched conditions in "Hospital Ernesto Dornelles" are
"Crohn Disease" (3 trials), "Crohn's Disease" (2 trials), "Ulcerative Colitis" (2 trials), "Acinetobacter Infections" (1 trials) and "Bacteremia" (1 trials). Many other conditions were trialed in "Hospital Ernesto Dornelles" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Ernesto Dornelles
Most popular intervention types in "Hospital Ernesto Dornelles" are "Drug" (16 trials), "Other" (8 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Etrolizumab" (4 trials), "Guselkumab Dose 1" (2 trials), "Guselkumab Dose 2" (2 trials) and "Guselkumab Dose 3" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Ernesto Dornelles
The vast majority of trials in "Hospital Ernesto Dornelles" are
19 trials for "All" genders and 3 trials for "Male" genders.
Clinical Trials Status at Hospital Ernesto Dornelles
Currently, there are NaN active trials in "Hospital Ernesto Dornelles".
undefined are not yet recruiting,
6 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Hospital Ernesto Dornelles,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Ernesto Dornelles, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".